Value share of pharmaceutical subsectors worldwide 2003 vs. 2021

Value share of the pharmaceutical market worldwide in 2003 and 2021, by subsector*

Exclusive Premium statistic

You need a Statista Account for unlimited access.

  • Full access to 1m statistics
  • Incl. source references
  • Available to download in PNG, PDF, XLS format
Statista Accounts

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Use Ask Statista Research Service

Release date

November 2021



Survey time period

2003 and 2021

Supplementary notes

* Value means value of the commercial side of the drug sector. Torreya estimates it at approximately $7.03 trillion. Of this, $6.1 trillion is associated with publicly-traded companies.
In this statistic “Big pharma” is classified as the 18 largest companies in the sector by value. The biotech sector seems smaller than some might have expected. This is because we classify a company with no approved product as a “biotechnology company” and a company with a marketed product that is not a big pharma, not a Japan pharma nor a China branded generic pharma as a branded pharma company. Thus, many companies (think Incyte or Biogen) that some would think of as biotech are classified by us as branded pharma.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Professional Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical market worldwide"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.